VISIOMED GROUP: Information relating to the total number of voting rights and the number of shares making up the share capital – 02/12/2022 at 6:00 p.m.


Paris, December 2, 2022

VISIOMED GROUP (FR0013481835 – ALVMG) publishes information relating to the total number of voting rights and the number of shares making up its share capital, in accordance with the provisions of article 223-16 of the General Regulations of the Autorité des marchés financiers .

Date

Number of actions

Number of voting rights

December 2, 2022

294 354 394

Theoretical

294 388 672

Exercisable

1

294 300 881

1

The total number of exercisable voting rights is calculated on the basis of all the theoretical voting rights minus the shares deprived of voting rights.

The number of shares created (24 shares) since November 3, 2022 comes from the exercise of 5,824 stock warrants (BSA).

About Visiomed Group

Created in 2007, Visiomed Group relies on a long experience in the health sector to invest in innovative health technologies and services in France and abroad.

The Group now has two wholly-owned subsidiaries:

  • BewellConnect, created in 2014, pioneer in connected health and teleconsultation solutions

BewellConnect offers an enriched technological universe, both in medical devices and software, making it possible to respond to all telehealth use cases: enriched and assisted teleconsultation, home telemonitoring, hospital monitoring, tele-expertise, teleassistance and tele-regulation.

BewellConnect’s flagship product, VisioCheck, is the 1

time

telemedicine station weighing less than 300g for healthcare professionals, available in case, station or modular health space.

BewellConnect is now deploying its solutions in France and abroad.

  • Smart Salem, the first digital medical analysis center accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates

The Smart Salem offer is based on know-how in medical analysis, radiology and data analysis and processing to detect nearly 35 diseases in 7 minutes in a patient (in particular HIV, hepatitis and tuberculosis) by offering reliable results. , readability and exceptional patient experience enabled by advanced artificial intelligence and virtual reality technologies.

Smart Salem’s “Medical Fitness Assessment” offer resulting from this know-how thus makes it possible to obtain a residence or work visa in the space of 30 minutes.

Smart Salem is a technological platform offering many growth opportunities, as shown by the opening of the second center in Dubai in September 2022 and the authorization received for the opening of a third center in the first quarter of 2023.

Based in Paris, Visiomed Group is listed on Euronext Growth (ALVMG). More information on www.visiomed-group.com, smartsalem.ae and www.bewell-connect.com.

CONTACTS

Jérôme FABREGUETTES-LEIB

Nawel NAAMANE

Investor Relations

Financial Press Relations

[email protected]

[email protected]

Phone: 01 53 67 36 78

Phone: 01 53 67 36 75

© Visiomed Group SA 2022. The brands mentioned are the property of their respective authors. Reproduction prohibited, even partial, without prior authorization.


This post has the “? Actusnews SECURITY MASTER” service.


– SECURITY MASTER Key:

nWxqZZZqYpqZlm2blppta5NmbpljlmabmWTIlWhvl8nKZ5uRyJtpZ5adZnBomWxo

– To check this key:

https://www.security-master-key.com.



Regulated information:


Total number of voting rights and capital:

– Information relating to the total number of voting rights and shares making up the capital


Full and original press release in PDF format:

https://www.actusnews.com/news/77472-alvmg_cp_ddv_20221202.pdf

© Copyright Actusnews Wire

Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com



Source link -86